Anna I. Kakafika

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study

Vasilios G. Athyros, Dimitri P. Mikhailidis, Triantafyllos Didangelos et al. · Current Medical Research and Opinion · 2006 · 245 citations

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study

Vasilios G. Athyros, D. P. Mikhailidis, Evangelos Liberopoulos et al. · Nephrology Dialysis Transplantation · 2006 · 184 citations

Association of Drinking Pattern and Alcohol Beverage Type With the Prevalence of Metabolic Syndrome, Diabetes, Coronary Heart Disease, Stroke, and Peripheral Arterial Disease in a Mediterranean Cohort

Vasilios G. Athyros, Evangelos Liberopoulos, Dimitri P. Mikhailidis et al. · Angiology · 2007 · 153 citations

Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia

Haralampos J. Milionis, Anna I. Kakafika, Sofia Tsouli et al. · American Heart Journal · 2004 · 152 citations

Metabolic Syndrome, Hypertension, Cardiovascular Disease +10

Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism

Asterios Karagiannis, Anna I. Kakafika, Efstathios D. Pagourelias et al. · Expert Opinion on Pharmacotherapy · 2008 · 133 citations

Hypertension, Heart Failure, Adrenal Gland +15